Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Process

  2.3.2 Market Size By Technology

  2.3.3 Market Size By Drug Type

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

 4.1 Pricing Analysis & Forecast

  4.1.1 Overview

  4.1.2 ricing Analysis & Forecast by Drug Type, 2022–2035

     4.1.3 Price Benchmarking by Key Players, 2025

     4.1.4 Drug Discovery Software and Platform Cost Analysis

     4.1.5 Clinical Research and Preclinical Testing Cost Trends

 4.2 Regulatory Landscape

  4.2.1 Overview

  4.2.2 Regulatory Trends by Key Countries

  4.2.3 Regulatory Outlook by Drug Type and Technology

     4.2.4 FDA, EMA, and PMDA Drug Discovery Guidelines

     4.2.5 Orphan Drug and Accelerated Approval Framework Analysis

 4.3 Trade Analysis

  4.3.1 Overview

  4.3.2 Import Analysis (Value & Volume), By Country, 2021–2025

  4.3.3 Export Analysis (Value & Volume), By Country, 2021–2025

  4.3.4 Major Importing Countries

  4.3.5 Major Exporting Countries

 4.4 Therapeutic Area Insights

  4.4.1 Oncology Drug Discovery Pipeline Analysis

     4.4.2 Neurological and Neurodegenerative Research Trends

     4.4.3 Rare Disease and Orphan Drug Development Analysis

     4.4.4 Infectious Disease and Vaccine Discovery Trends

5. Drug Discovery Market Segmental Analysis & Forecast, By Process, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Target Identification & Validation

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Hit-to-Lead Identification

 5.4 Candidate Validation

 5.5 Others

6. Drug Discovery Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 High-Throughput Screening

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Bioinformatics

 6.4 Molecular Modeling & Simulation

 6.5 Genomics

 6.6 Others

7. Drug Discovery Market Segmental Analysis & Forecast, By Drug Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Small Molecules

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Biologics

 7.4 Others

8. Drug Discovery Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Pharmaceutical & Biotechnology Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Contract Research Organizations

 8.4 Academic & Research Institutes

 8.5 Others

9. Drug Discovery Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Drug Discovery Market Size & Forecast, By Process, 2022–2035

 9.2.3 Drug Discovery Market Size & Forecast, By Technology, 2022–2035

 9.2.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022–2035

 9.2.5 Drug Discovery Market Size & Forecast, By End User, 2022–2035

 9.2.6 Drug Discovery Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Drug Discovery Market Size & Forecast, By Process, 2022–2035

 9.3.3 Drug Discovery Market Size & Forecast, By Technology, 2022–2035

 9.3.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022–2035

 9.3.5 Drug Discovery Market Size & Forecast, By End User, 2022–2035

 9.3.6 Drug Discovery Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Drug Discovery Market Size & Forecast, By Process, 2022–2035

 9.4.3 Drug Discovery Market Size & Forecast, By Technology, 2022–2035

 9.4.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022–2035

 9.4.5 Drug Discovery Market Size & Forecast, By End User, 2022–2035

 9.4.6 Drug Discovery Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Drug Discovery Market Size & Forecast, By Process, 2022–2035

 9.5.3 Drug Discovery Market Size & Forecast, By Technology, 2022–2035

 9.5.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022–2035

 9.5.5 Drug Discovery Market Size & Forecast, By End User, 2022–2035

 9.5.6 Drug Discovery Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Drug Discovery Market Size & Forecast, By Process, 2022–2035

 9.6.3 Drug Discovery Market Size & Forecast, By Technology, 2022–2035

 9.6.4 Drug Discovery Market Size & Forecast, By Drug Type, 2022–2035

 9.6.5 Drug Discovery Market Size & Forecast, By End User, 2022–2035

 9.6.6 Drug Discovery Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Process/Service & Technology Benchmarking

  10.4.1 Process/Service Specifications & Features By Key Players

  10.4.2 Process/Service Heatmap By Key Players

  10.4.3 Technology Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Eli Lilly

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Process/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

  10.6.2 Johnson & Johnson

     10.6.3 AbbVie

     10.6.4 Merck & Co.

  10.6.5 Roche

     10.6.6 Pfizer

     10.6.7 AstraZeneca

     10.6.8 Novartis

     10.6.9 Bayer

     10.6.10 GlaxoSmithKline (GSK)

     10.6.11 Amgen

     10.6.12 Sanofi

     10.6.13 Bristol Myers Squibb

     10.6.14 Abbott Laboratories

    10.6.15 Gilead Sciences

    10.6.16 Regeneron Pharmaceuticals

    10.6.17 Vertex Pharmaceuticals

    10.6.18 Eisai Co., Ltd.

    10.6.19 Takeda Pharmaceutical Company

    10.6.20 Biogen

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures